Pancreatic Cancer Research

ResearcherTongji HospitalActive in the last 2 years

Shuo Yu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8166-636X; OpenAlex author ID A5101873390. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 4

  1. Resistance to gemcitabine is mediated by the circ_0036627/miR-145/S100A16 axis in pancreatic cancer. Co-author DOI 10.1111/jcmm.18444↗
  2. Circ_0092367 Inhibits EMT and Gemcitabine Resistance in Pancreatic Cancer via Regulating the miR-1206/ESRP1 Axis. Co-author DOI 10.3390/genes12111701↗
  3. Upregulation of METTL14 mediates the elevation of PERP mRNA N6 adenosine methylation promoting the growth and metastasis of pancreatic cancer. Co-author DOI 10.1186/s12943-020-01249-8↗
  4. Three-lncRNA signature is a potential prognostic biomarker for pancreatic adenocarcinoma. Co-author DOI 10.18632/oncotarget.24443↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xingjun Guo · 4 shared papers, 2018–2024 · strength 0.61
  2. Min Wang · 3 shared papers, 2018–2021 · strength 0.33
  3. Renyi Qin · 3 shared papers, 2018–2021 · strength 0.33
  4. Renyi Qin · 1 shared paper, 2024 · strength 0.28
  5. Yan Zhao · 2 shared papers, 2018–2020 · strength 0.16
  6. Ruizhi He · 2 shared papers, 2018–2020 · strength 0.16
  7. Li Xu · 1 shared paper, 2020 · strength 0.08
  8. Jun Gong · 1 shared paper, 2020 · strength 0.08
  9. Xiaodong Xu · 1 shared paper, 2020 · strength 0.08
  10. Chengjian Shi · 1 shared paper, 2020 · strength 0.08
  11. Min Li · 1 shared paper, 2020 · strength 0.08
  12. Jianxin Jiang · 1 shared paper, 2020 · strength 0.08
  13. Shutao Pan · 1 shared paper, 2018 · strength 0.08
  14. Xiuhui Shi · 1 shared paper, 2018 · strength 0.08
  15. Min Zhou · 1 shared paper, 2018 · strength 0.08
  16. Xu Li · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.